We are live on
!
Find out more
EMB
Elefante Mark B Portfolio holdings
AUM
$182M
1-Year Est. Return
17.71%
This Fund
S&P 500
This Quarter
Est. Return
+2.06%
1 Year Est. Return
+17.71%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.64M
AUM Growth
+$379K
(+6.1%)
Cap. Flow
+$270K
Cap. Flow
% of AUM
4.07%
Top 10 Holdings %
Top 10 Hldgs %
58.69%
Holding
21
New
1
Increased
9
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$204K |
| 2 |
Chubb
CB
|
+$22.2K |
| 3 |
Novartis
NVS
|
+$17K |
| 4 |
Abbott
ABT
|
+$12.7K |
| 5 |
RTX Corp
RTX
|
+$9.15K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$15.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.23% |
| 2 | Technology | 21.45% |
| 3 | Industrials | 13.34% |
| 4 | Consumer Staples | 12.27% |
| 5 | Financials | 9.38% |
Similar funds
CIA
HWM
AFS
TFP
CFG
CFG
NED
RS
Elefante Mark B's Q2 2016 Portfolio in Review
As of Q2 2016, Elefante Mark B held 21 positions worth $6.64M, up 6.1% from $6.26M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Elefante Mark B deployed $270K of net new capital in Q2 2016, opening 1 new position and adding to 9 existing holdings. Its largest new stake was Unilever: 3,969 shares worth $215K.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Fiserv Inc, an estimated $15.4K trimmed.
- Elefante Mark B's largest Q2 2016 buy was Unilever: 3,969 shares worth $215K.
- Elefante Mark B added most to Chubb in Q2 2016, an estimated $22.2K increase.
- Elefante Mark B's biggest Q2 2016 reduction was Fiserv Inc, cutting an estimated $15.4K.
- Elefante Mark B's ten largest holdings make up 59% of its $6.64M portfolio in Q2 2016.
- Elefante Mark B opened 1 new position and closed 0 in Q2 2016.
- Elefante Mark B's portfolio value rose 6.1% quarter-over-quarter to $6.64M.
Based on Elefante Mark B's 13F filing for Q2 2016, filed 8 Aug 2016.